Edit

Jeeva Informatics Solutions Inc.

https://jeevatrials.com/

Last activity: 24.02.2026

Active

Categories: HardwareHealthTechLearnMedtechMobilePlatformResearchServiceSoftwareTime

The personal experience of losing a child born with a rare disease and a brother with a chronic disease became the springboard for Dr. Harsha Rajasimha to apply his years of postdoctoral training at NIH and FDA to accelerating therapies for rare and common conditions. He knew that technology in itself is not the limiting factor and that patient-centered design guided by stakeholder needs and regulatory requirements would guide their continuous learning digital platform. By digitizing and automating manual repetitive tasks and reducing the logistical burdens on patients and study teams by over 70%, Jeeva accelerates the process of bringing new medicines or vaccines to patients who need them by over 3x faster. The Virginia-based company’s modular software-as-a-service platform is fully scalable and facilitates patient enrollment, engagement, and evidence generation in clinical trials on any browser-enabled mobile device. Visit https://jeevatrials.com/

Likes

374

Followers

366

Website visits

9.7K /mo.

Mentions

Location: United States, Virginia, Vienna

Employees: 11-50

Founded date: 2019

Investors 1

Date	Name	Website
19.11.2021	RAMP Accel...	ramprb.com

Mentions in press and media 24

Date	Title	Description
24.02.2026	Jeeva Clinical Trials Calls on Global Life Sciences Leaders to Modernize Infrastructure for AI-Driven Drug Development	Jeeva Clinical Trials Calls on Global Life Sciences Leaders to Modernize Infrastructure for AI-Driven Drug Development A visionary foundational platform for AI-powered clinical trials Jeeva Clinical Trials Inc Logo Clinical Trials suffer du...
10.09.2025	Jeeva Clinical Trials Launches Transparent Pricing Framework to Cut Through Opaque eClinical Maze	Jeeva Clinical Suite Transparent Per Participant Per Month Pricing Sheet for Observational and Interventional trials across therapeutic areas and phases. Jeeva AI Agent for Customers and User Support Jeeva Clinical Trials Inc Logo A new per...
18.03.2025	Jeeva Clinical Trials Unveils Partnership Program to Accelerate Next-Gen Clinical Trials with Unified, AI-Driven CTMS	Jeeva Clinical Trials Products and AI Solutions with CTMS. The image is generated using Dall-E AI tool. Jeeva Clinical Trials Inc Logo Visionary Leader of revolutionizing Clinical Trials with technology and AI Jeeva Clinical Trials, a leade...
07.01.2025	IR Centers Collaborates with Jeeva Clinical Trials to Revolutionize Patient Outcomes in Interventional Radiology	Jeeva Clinical Trials Inc Founder and CEO Harsha K Rajasimha, PhD, at the BlinkPad Nexus event at JP Morgan Healthcare Investor Conference 2025 Jeeva Clinical Trials Inc Logo Pharmaceutical Outsourcing Documentary Video Thumbnail Image Jeev...
16.07.2024	Walking the Talk of Patient-Centricity in Cell and Gene Therapy Trials	JEEVA PRS 3 Remarkable progress in the development of cell and gene therapies (CGTx) has ignited hope for millions of patients battling debilitating human diseases including Central Nervous System (CNS) and neuromuscular diseases. However, ...
13.05.2024	Cancer Moonshot Gets a Booster Shot from This AI-Driven Clinical Research Platform	JEEVA PRS 2 President Biden's loss of his beloved son to brain cancer in 2015 inspired the Cancer Moonshot initiative. Dr. Harsha Rajasimha's inspiration for founding Jeeva Clinical Trials in 2019 stemmed from a similar incident: losing his...
12.03.2024	AI or Bye: Revolutionizing Clinical Trials with Cutting-Edge Technology	Jeeva All In One Platform Jeeva Clinical Trials is revolutionizing drug development by integrating AI and automated workflows into clinical trials, significantly reducing the time and cost of bringing treatments to market. Led by Dr. Harsha...
12.09.2023	From Protocol to Publication: Reducing Costs and Maximizing Efficiency for Investigator-Initiated Trials	The cost of clinical trials can range from $100,000 to well over $30 million, with significant variations based on factors such as the trial type, development phase, and focus of treatment Dr. Harsha Rajasimha, Founder and CEO of Jeeva Info...
07.08.2023	The Inflation Reduction Act: How Price Controls Could Disrupt Clinical Trials and Stifle Medical Innovation	Clinical Trials and Medical Innovation Mid-market and emerging pharma companies can achieve their pivotal clinical trial milestones with a unified trial management system that offers a high-value solution, addressing the most pressing probl...
27.06.2023	The FDA Inspires Confidence in Decentralized Clinical Trials With New Guidance for Future Success	Collecting, tracking, and analyzing data in real-time generates immediately actionable insights and helps to identify opportunities, reduce risk, and make better decisions TYSONS CORNER, Va. (PRWEB) June 27, 2023 As of June 2023, there are ...
27.06.2023	VIPC Awards Commonwealth Commercialization Fund Grant to Jeeva Informatics Solutions Inc.	CCF grants support startups, critical early technology testing and market validation efforts This funding will enable us to achieve the next milestones in our mission to drive efficiencies and access to therapies for patients everywhere.” —...
25.04.2023	Biggest Risk Factors for Emerging and Mid-market Biopharma Companies, Costly Clinical Trial Delays	The risks are highest at the beginning. Persistent pain points plague every clinical trial, such as the inevitable protocol amendments that need to be planned for rather than reacting to them as a surprise—which can exponentially delay the ...
03.01.2023	Removing Socioeconomic Barriers and Increasing Diversity in Clinical Trials Would Have a Positive Economic Impact	Between logistical burdens, distrust in the healthcare system, and lack of awareness and information in many non-English languages, key demographic groups like women, children, low-income households, and racial and ethnic minorities are eff...
26.10.2022	New Jeeva eClinical Research Technology Enables Global Diversity Inclusion and Multi-Center Collaboration	Empowering remote patient-researcher interactions through the use of human-centric digital technology enables us to deliver dramatic improvements in the diversity of study populations scalable to a variety of clinical trials with rapid conf...
12.07.2022	Innovation in Use of Electronic Patient Reported Outcomes Is Closing The Digital Divide	The infrastructure for widespread ePROM-based research exists and can be made more accessible by the use of BYOD—bring your own device technology architecture. For improved clinical research, investigators and researchers may need to captur...
05.04.2022	Technology Being Challenged by Upsurge in Decentralized Clinical Trials	While diabetes, hypertension, and respiratory tract infection are slated for significantly increased testing, decentralized clinical trial design is expected to increase 28% this year over 2021. Technology platforms partnered with a systems...
14.02.2022	Management of Pediatric Clinical Trials Calls for Urgent Technological Innovation	Of the 93% of the overall American population affected by rare diseases, 50% are children. Meanwhile, the time it takes for a patient to get an accurate rare disease diagnosis is six to eight years. A consultative and collaborative human-ce...
11.01.2022	Decentralized Clinical Trials Raise Concerns About Informed Consent	Due to the pandemic, clinical trials have taken a more digital approach, but recent research shows a worrying lack of patients’ informed consent to the treatment they are undergoing. With digital communication, prospective clinical trial pa...
01.12.2021	Clinical Research Processes Struggle to Adapt Amidst Pandemic	The pandemic has intensified worldwide research collaboration and a reprioritization and rethinking of the process of how healthcare is delivered or received. If clinical trials for the COVID vaccines—research, development, and approval—wer...
22.11.2021	Human-Centric eClinical Platforms Can Eliminate Inefficiencies Rooted in Traditional Clinical Trials	A recent study shows that about 85 percent of clinical trials of new drugs and medical devices will experience delays, and over 90 percent of them for a month or longer. The solution to [clinical trial delays] ... lies in the adoption of a ...
12.10.2021	Distrust, Fear Hamper COVID Vaccinations, Clinical Trial Diversity	Researchers studied 400 reports from around the world and found that fear about testing new treatments was the most common reason given for not participating in clinical trials. The medical research community needs to plan and work toward e...
20.09.2021	Patient-Centric Approach to Clinical Trials Improves Outcomes for All Stakeholders	Improving the success rate of clinical trials is an urgent matter on every level—recruitment, retention, testing, diversity and educating the patient, among others. Current statistics show that 85% of all clinical trials are delayed during ...
31.08.2021	Decentralized Clinical Trials Boost Enrollment, Increase Patient Diversity	Historically, clinical trials—administering medication, gathering patient data, etc.—have taken place at a clinical trial site. To a great extent, this is no longer necessary. Decentralization has proven to be highly beneficial to sponsors ...
19.07.2021	New Technology to Help Increase Patient Diversity in Clinical Trials	There needs to be global participation in clinical trials if results are to be trusted when applied to people from different racial, ethnic, gender and age backgrounds. How can a drug aimed at the general public be trusted if its effect on ...

Jeeva Informatics Solutions Inc.

Investors 1

Mentions in press and media 24

Reviews 0